SEC 13F Intelligence

Managers / Q1 2026

Duquesne Family Office LLC

CIK 0001536411 · Part of the Duquesne family · 40 WEST 57TH STREET, 25TH FLOOR, NEW YORK, NY, 10019 · (212) 830-6500

Reported Value
$3.4B
Q1 2026
Positions
70
Filings on Record
32
2019–present window
Filed
May 15, 2026
original filing

Summary

Duquesne Family Office LLC reported $3.4B in U.S.-listed holdings across 70 positions for Q1 2026.

Its largest position, NTRA, represents 18.1% of the portfolio.

Compared with Q4 2025, the fund opened 30 new positions and exited 22.

Portfolio Metrics

Turnover
+22.5%
vs prior filed quarter
Top-10 Concentration
+51.5%
share of reported value
Largest Position
+18.1%
Natera
New / Exited
30 / 22
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $1.7BQ4 ’18Q1 ’19: $3.4BQ2 ’19: $3.4BQ3 ’19: $2.6BQ4 ’19: $3.4BQ4 ’19Q1 ’20: $2.5BQ2 ’20: $3.3BQ3 ’20: $3.4BQ4 ’20: $3.7BQ4 ’20Q1 ’21: $4.5BQ2 ’21: $4.0BQ3 ’21: $3.1BQ4 ’21: $2.8BQ4 ’21Q1 ’22: $2.3BQ2 ’22: $1.4BQ3 ’22: $1.8BQ4 ’22: $2.0BQ4 ’22Q1 ’23: $2.3BQ2 ’23: $2.9BQ3 ’23: $2.8BQ4 ’23: $3.4BQ4 ’23Q1 ’24: $4.4BQ2 ’24: $2.9BQ3 ’24: $3.0BQ4 ’24: $3.7BQ4 ’24Q1 ’25: $3.1BQ2 ’25: $4.1BQ3 ’25: $4.1BQ4 ’25: $4.5BQ4 ’25Q1 ’26: $3.4Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 61.0%ETP: 17.4%ADR: 15.7%Other: 3.3%NY Reg Shrs: 2.7%
  • Common Stock · 61.0% · $2.1B
  • ETP · 17.4% · $587M
  • ADR · 15.7% · $531M
  • Other · 3.3% · $110M
  • NY Reg Shrs · 2.7% · $90M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2025 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
AVGOBroadcom IncNEW+196.0K196.0K+$61M$61M
ARGTGlobal X FdsNEW+387.4K387.4K+$36M$36M
CAICaris Life Sciences IncNEW+1.89M1.89M+$34M$34M
RVMDRevolution Medicines IncNEW+315.9K315.9K+$31M$31M
SNDKSandisk CorpNEW+38.2K38.2K+$24M$24M
HUMHumana IncNEW+137.5K137.5K+$24M$24M
TWLOTwilio IncNEW+181.8K181.8K+$23M$23M
JBLJabil IncNEW+82.2K82.2K+$22M$22M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2026

65 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NTRANatera Inchistory →COM18.14%$613M3.06M
2INSMInsmed Inchistory →COM PAR $.015.59%$189M1.15M
3TSMTaiwan Semiconductor Manufachistory →SPONSORED ADS4.96%$167M495.3K
4YPFYpf Sociedad Anonimahistory →SPON ADR CL D4.43%$150M3.24M
5EWZIshares Inchistory →MSCI BRAZIL ETF3.91%$132M3.44M
6Bbb Foods IncCL A COM3.26%$110M3.11M
7AAAlcoa Corphistory →COM2.93%$99M1.49M
8NAMSNewamsterdam Pharma Companyhistory →ORDINARY SHARES2.91%$98M3.07M
9SESea Ltdhistory →SPONSORD ADS2.70%$91M1.10M
10STMStmicroelectronics N Vhistory →NY REGISTRY2.67%$90M2.61M
11WWDWoodward Inchistory →COM2.24%$76M211.4K
12TEVATeva Pharmaceutical Inds Ltdhistory →SPONSORED ADS2.12%$72M2.38M
13ROKURoku Inchistory →COM CL A2.10%$71M750.2K
14AVGOBroadcom Inchistory →COM1.80%$61M196.0K
15CPNGCoupang Inchistory →CL A1.49%$50M2.67M
16OPCHOption Care Health Inchistory →COM NEW1.49%$50M1.87M
17CRHCrh Plchistory →ORD1.18%$40M377.6K
18FIGRFigure Technology Solutiohistory →COM CL A1.16%$39M1.15M
19ARGTGlobal X Fdshistory →GB MSCI AR ETF1.07%$36M387.4K
20CAICaris Life Sciences Inchistory →COM1.00%$34M1.89M
21QSRRestaurant Brands Intl Inchistory →COM0.99%$34M454.4K
22RVMDRevolution Medicines Inchistory →COM0.91%$31M315.9K
23LSCCLattice Semiconductor Corphistory →COM0.89%$30M323.1K
24SNDKSandisk Corphistory →COM0.72%$24M38.2K
25UALUnited Airls Hldgs Inchistory →COM0.72%$24M262.5K
26HUMHumana Inchistory →COM0.71%$24M137.5K
27WABWabtechistory →COM0.70%$24M94.9K
28TWLOTwilio Inchistory →CL A0.68%$23M181.8K
29JBLJabil Inchistory →COM0.65%$22M82.2K
30SCCOSouthern Copper Corphistory →COM0.62%$21M121.8K
31GSGIshares S&P Gsci Commodity-history →UNIT BEN INT0.61%$21M643.0K
32LINLinde Plchistory →SHS0.60%$20M41.2K
33STXSeagate Technology Hldngs Plhistory →ORD SHS0.59%$20M50.7K
34CLFCleveland-Cliffs Inc Newhistory →COM0.58%$20M2.31M
35NUVBNuvation Bio Inchistory →COM CL A0.58%$19M4.54M
36BEBloom Energy Corphistory →COM CL A0.55%$18M136.3K
37INTCIntel Corphistory →COM0.54%$18M411.4K
38BLTEBelite Bio Inc Sponsoredhistory →ADS0.50%$17M106.1K
39PTGXProtagonist Therapeutics Inchistory →COM0.50%$17M159.7K
40UUnity Software Inchistory →COM0.48%$16M738.8K
41ARMArm Holdings Plchistory →SPONSORED ADS0.48%$16M106.7K
42OLMAOlema Pharmaceuticals Inchistory →COM0.44%$15M986.8K
43QQnity Electronics Inchistory →COMMON STOCK0.43%$14M125.7K
44ADMAAdma Biologics Inchistory →COM0.41%$14M1.55M
45XENEXenon Pharmaceuticals Inchistory →COM0.41%$14M238.6K
46Jbs N.V.CL A SHS0.35%$12M655.9K
47DAKTDaktronics Inchistory →COM0.33%$11M562.6K
48NETCloudflare Inchistory →CL A COM0.32%$11M52.5K
49LYBLyondellbasell Industries Nvhistory →SHS - A -0.31%$11M131.4K
50VISTVista Energy S.A.B. De C.V.history →SPONSORED ADS0.30%$10M134.7K
51TWSTTwist Bioscience Corphistory →COM0.29%$10M206.0K
52COHRCoherent Corphistory →COM0.29%$10M40.4K
53AMZNAmazon Com Inchistory →COM0.28%$10M45.8K
54CLSCelestica Inchistory →COM0.28%$9M33.3K
55STUBStubhub Hldgs Inchistory →CL A0.25%$9M1.37M
56DBVTDbv Technologies S A Sponsoredhistory →ADS0.24%$8M383.4K
57MUMicron Technology Inchistory →COM0.23%$8M23.4K
58ECHOEchostar Corphistory →CL A0.21%$7M60.8K
59ALMAlmonty Inds Inchistory →COM NEW0.20%$7M469.9K
60PCTPurecycle Technologies Inchistory →COM0.15%$5M963.2K
61LITELumentum Hldgs Inchistory →COM0.14%$5M7.0K
62MELIMercadolibre Inchistory →COM0.14%$5M2.8K
63SOLSSolstice Advanced Matls Inchistory →COM SHS0.14%$5M62.5K
64WLKWestlake Corporationhistory →COM0.07%$2M21.2K
65WVEWave Life Sciences Ltdhistory →SHS0.04%$1M173.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$3.4B70May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$4.5B62Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$4.1B65Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$4.1B69Aug 15, 202513F-HRchanges · EDGAR ↗
Q1 2025$3.1B52May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$3.7B78Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$3.0B75Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$2.9B64Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$4.4B73May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$3.4B51Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$2.8B41Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$2.9B53Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$2.3B48May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$2.0B58Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$1.8B65Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.4B43Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$2.3B51May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$2.8B49Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$3.1B49Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021REVEALED$4.0B52Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021REVEALED$4.5B64May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$3.7B56Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$3.4B61Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$3.3B72Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$2.5B46May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$3.4B62Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$2.6B43Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$3.4B61Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$3.4B61May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$1.7B31Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.